MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on February 23, 2006; DOI: 10.1124/mol.105.019729


0026-895X/06/6905-1673-1683$20.00
Mol Pharmacol 69:1673-1683, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.019729v1
69/5/1673    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Restano-Cassulini, R.
Right arrow Articles by Wanke, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Restano-Cassulini, R.
Right arrow Articles by Wanke, E.

Species Diversity and Peptide Toxins Blocking Selectivity of Ether-à-go-go-Related Gene Subfamily K+ Channels in the Central Nervous System

Rita Restano-Cassulini, Yuliya V. Korolkova, Sylvie Diochot, Georgina Gurrola, Leonardo Guasti, Lourival D. Possani, Michel Lazdunski, Eugene V. Grishin, Annarosa Arcangeli, and Enzo Wanke

Dipartimento di Biotecnologie e Bioscienze, Università di Milano-Bicocca, Milano, Italy (R.R.-C., E.W.); Shemyakin-Ovchinnikov Intitute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia (Y.V.K., E.V.G.); Institut de Pharmacologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique-Unité Mixte Recherche, Valbonne, France (S.D., M.L.); Department of Molecular Medicine and Bioprocesses, Institute of Biotechnology, National Autonomous University of Mexico, Cuernavaca, Mexico (G.G., L.D.P.); and Dipartimento di Patologia e Oncologia Sperimentali, Università di Firenze, Firenze, Italy (L.G., A.A.)

The ether-à-go-go-related gene (erg) K+ channels are known to be crucial for life in Caenorhabditis elegans (mating), Drosophila melanogaster (seizure), and humans (LQT syndrome). The erg genes known to date (erg1, erg2, and erg3) are highly expressed in various areas of the rat and mouse central nervous system (CNS), and ERG channel blockers alter firing accommodation. To assign physiological roles to each isoform, it is necessary to design pharmacological strategies to distinguish individual currents. To this purpose, we have investigated the blocking properties of specific peptide inhibitors of hERG1 channels on the human and rat isoforms. In particular, we have tested ErgTx1 (from the scorpion Centruroides noxious), BeKm-1 (from the scorpion Buthus eupeus), and APETx1 (from the sea anemone Anthopleura elegantissima). Because these peptides had different species-specific effects on the six different channels, we have also carried out a biophysical characterization of hERG2 and hERG3 channels that turned out to be different from the rat homologs. It emerged that APETx1 is exquisitely selective for ERG1 and does not compete with the other two toxins. BeKm-1 discriminates well among the three rat members. ErgTx1 is unable to block hERG2, but blocks rERG2 and has the lowest KD for hERG3. BeKm-1 and ErgTx1 compete for hERG3 but not for rERG2 blockade. Our findings should be helpful for structure-function studies and for novel CNS ERG-specific drug design.


Received for publication October 10, 2005.

Accepted for publication February 23, 2006.

Address correspondence to: Prof. Enzo Wanke, Dipartimento di Biotecnologie e Bioscienze Università di Milano-Bicocca, Piazza della Scienza 2, 20126 Milano, Italy. E-mail: enzo.wanke{at}unimib.it




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. B. Hardy, J. E. M. Fox, P. R. Giglou, N. Wijesekara, A. Bhattacharjee, S. Sultan, A. V. Gyulkhandanyan, H. Y. Gaisano, P. E. MacDonald, and M. B. Wheeler
Characterization of Erg K+ Channels in {alpha}- and {beta}-Cells of Mouse and Human Islets
J. Biol. Chem., October 30, 2009; 284(44): 30441 - 30452.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
I. A. Greenwood, S. Y. Yeung, R. M. Tribe, and S. Ohya
Loss of functional K+ channels encoded by ether-à-go-go-related genes in mouse myometrium prior to labour onset
J. Physiol., May 15, 2009; 587(10): 2313 - 2326.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Hagendorf, D. Fluegge, C. Engelhardt, and M. Spehr
Homeostatic Control of Sensory Output in Basal Vomeronasal Neurons: Activity-Dependent Expression of Ether-a-Go-Go-Related Gene Potassium Channels
J. Neurosci., January 7, 2009; 29(1): 206 - 221.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. Guasti, O. Crociani, E. Redaelli, S. Pillozzi, S. Polvani, M. Masselli, T. Mello, A. Galli, A. Amedei, R. S. Wymore, et al.
Identification of a Posttranslational Mechanism for the Regulation of hERG1 K+ Channel Expression and hERG1 Current Density in Tumor Cells
Mol. Cell. Biol., August 15, 2008; 28(16): 5043 - 5060.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Zhang, X.-S. Liu, S. Diochot, M. Lazdunski, and G.-N. Tseng
APETx1 from Sea Anemone Anthopleura elegantissima Is a Gating Modifier Peptide Toxin of the Human Ether-a-go-go- Related Potassium Channel
Mol. Pharmacol., August 1, 2007; 72(2): 259 - 268.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. Y. M. Yeung and I. A. Greenwood
Pharmacological and biophysical isolation of K+ currents encoded by ether-a-go-go-related genes in murine hepatic portal vein smooth muscle cells
Am J Physiol Cell Physiol, January 1, 2007; 292(1): C468 - C476.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics